Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bone Marrow Diseases × Electrocardiography × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 4 Lymphoma 4 Prostatic Neoplasms 3 Leukemia 3 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, B-Cell 2 Hematologic Neoplasms 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Initiation and Maintenance Disorders 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Papillomavirus Infections 1 Nose Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Effusion 1

Interventions

ponatinib 4 ruxolitinib 3 nilotinib 3 Imatinib Mesylate 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 sonidegib 1 simtuzumab 1 pembrolizumab 1 ibrutinib 1 bosutinib 1 Zoledronic Acid 1 Denosumab 1 BID protein, human 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡